Damora Therapeutics, Inc. (DMRA): 8-K filed Jul 20, 2026

Form type

8-K

Filing date

Jul 20, 2026

Accession number

0001193125-26-308899

Filer

Damora Therapeutics, Inc. (CIK 1800315)